Rebecca E. Chandler

Serious Neurological Adverse Events after Ivermectin—Do They Occur beyond the Indication of Onchocerciasis?

Rebecca E. Chandler · American Journal of Tropical Medicine and Hygiene · 2017 · 158 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®

Rebecca E. Chandler, Kristina Juhlin, Jonas Fransson et al. · Drug Safety · 2016 · 96 citations · Full text

Veterinary Medicine, Infectious Diseases, Epidemiology +15

Leveraging epidemiological principles to evaluate Sweden’s COVID-19 response

Stefan Baral, Rebecca E. Chandler, Ruth Prieto et al. · Annals of Epidemiology · 2020 · 70 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +15

Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase

Lovisa Sandberg, H. Taavola, Yasunori Aoki et al. · Drug Safety · 2020 · 62 citations · Full text

Pharmacy, Pharmacology, Clinical Epidemiology +16

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre

Sarah Watson, Rebecca E. Chandler, H. Taavola et al. · Drug Safety · 2017 · 56 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +16